Abstract

Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy

Author(s): Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J

Issue: Jul/Aug 2004 - Wound Care

Page(s): 313-319

Download in electronic PDF format for $75
  • Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Page 1
  • Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Page 2
  • Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Page 3
  • Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Page 4
  • Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Page 5
  • Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Page 6
  • Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Page 7

Abstract

The primary purpose of this six-week survey study of women currently taking compounded bioidentical hormone replacement therapy was to determine if compounded bioidentical hormone replacement therapy relieves symptoms of menopause and is well tolerated. The secondary purpose of this study was to compare the symptom relief and tolerability of compounded bioidentical hormone replacement therapy to previously used commercially available products. All strengths and dosage forms of bi-estrogen and triestrogen were included, whether used alone or in combination with progesterone, dehydroepiandrosterone or testosterone. The survey instrument consisted of nineteen questions and evaluated the outcomes and side effects for commercially available versus compounded bioidentical hormones.

A total of 160 surveys was distributed and 78 were completed. Overall, 57.7% of the women surveyed reported fewer side effects and 71.8% of the women had better relief of menopausal symptoms when using bioidentical hormone replacement therapy. The occurrence and severity of menopausal symptoms decreased significantly after beginning bioidentical hormone replacement therapy. Before treatment, moderate-to-severe symptoms of hot flashes, night sweats, sleep problems, dry skin/hair, vaginal dryness, foggy thinking, mood swings and decrease in sex drive were reported in 52% to 70% of the women. After initiating treatment the moderate-to-severe range of symptoms dropped to between 4% and 20%. The most commonly reported side effects with bioidentical hormone replacement therapy were weight gain (37.2%), breast tenderness (19.2%) and bloating (23.1%). Weight gain (56.2%), breast tenderness (54.5%), bloating (40%) and mood swings (36.4%) were most commonly seen with commercially available products.

Bioidentical hormone replacement relieved the symptoms of menopause and was well tolerated.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2004
Pg. 313-319
Jan/Feb 2015
Pg. 6-12
Jan/Feb 2002
Pg. 50-54
Author(s): Wepfer Scott T
Mar/Apr 2002
Pg. 142-146
Author(s): Wepfer Scott T
Sep/Oct 2016
Pg. 359-364
Author(s): Deleruyelle Laura J
Jul/Aug 2005
Pg. 266
Author(s): White Irene Q
Mar/Apr 2010
Pg. 165-170
Nov/Dec 2016
Pg. 447-454
Author(s): Deleruyelle Laura J
Jul/Aug 2011
Pg. 290-300
Jul/Aug 2003
Pg. 250-256
Jan/Feb 2017
Pg. 6-16
Author(s): Deleruyelle Laura J
Jan/Feb 2001
Pg. 52-54
Author(s): Ford Gina, Garcia Lea
Sep/Oct 2009
Pg. 392-399
Sep/Oct 2002
Pg. 378
Author(s): Santoro Filippo
Jan/Feb 2003
Pg. 24-26
Author(s): Vail Jane
Jul/Aug 2007
Pg. 292-296
Sep/Oct 2010
Pg. 374-380
Author(s): Bramwell Bethany L
Jul/Aug 2007
Pg. 269-272
Jan/Feb 2013
Pg. 74-85
View Sample
Jan/Feb 2014
Pg. 70-77